• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Industrials·BNCM
Share

Bounce Mobile Systems, Inc. Stocks

$ 0.01Last Updated 27.07.2026

Issuer Rating

3/7
Performance

Average

Risk

High

Recommendation

Sell

Market Cap

$ 19.00M

$ 0.01
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Bounce Mobile Systems, Inc. engages in the development and distribution of pharmaceutical and healthcare products in Asia and the Philippines. It also engages in the development, distribution, and trading of medical supplies, equipment, pharmaceutical products, and food supplements. In addition, the company offers medical devices and machines, such as cardiovascular ultrasounds; needless connectors and IV lines; and ambulatory/PCA infusion pumps for critical care, anti-infectives, and anesthesia, as well as provides after sales services. It also sells its products through online drugstore. Bounce Mobile Systems, Inc. was formerly known as Delex Healthcare Group, Inc. and changed its name to Bounce Mobile Systems, Inc. in October 2024. The company was incorporated in 2017 and is based in New York, New York.

Company Valuation

Fairly valued
4/7

Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. In particular, the stock is trading at neutral levels on P/FCF

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

22.10.2026 11:49

Meta is ramping up its investment in AI: increasing spending and preparing to issue a new class of shares

22.10.2026 11:15

Tesla has scaled back its capital expenditure plans for 2026. Why investors weren't pleased

22.10.2026 10:48

Top Stories This Morning: Meta Has Increased Its AI Spending; Anthropic Has Unveiled a Competitor to Muse

22.10.2026 10:33

Millions of Hacking Attempts: 5 Questions About a Critical Network Vulnerability Discovered by AI

21.10.2026 22:53

"Ambitions Greater Than Anyone Else's": JPMorgan Expects SpaceX Shares to Triple in Value

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026